IL150090A0 - New (aminopropyl)methylphosphinic acids - Google Patents
New (aminopropyl)methylphosphinic acidsInfo
- Publication number
- IL150090A0 IL150090A0 IL15009000A IL15009000A IL150090A0 IL 150090 A0 IL150090 A0 IL 150090A0 IL 15009000 A IL15009000 A IL 15009000A IL 15009000 A IL15009000 A IL 15009000A IL 150090 A0 IL150090 A0 IL 150090A0
- Authority
- IL
- Israel
- Prior art keywords
- aminopropyl
- new
- methylphosphinic
- acids
- methylphosphinic acids
- Prior art date
Links
- NHVRIDDXGZPJTJ-UHFFFAOYSA-N skf-97,541 Chemical class CP(O)(=O)CCCN NHVRIDDXGZPJTJ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904507A SE9904507D0 (sv) | 1999-12-09 | 1999-12-09 | New compounds |
| PCT/SE2000/002427 WO2001041743A1 (en) | 1999-12-09 | 2000-12-04 | New (aminopropyl)methylphosphinic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150090A0 true IL150090A0 (en) | 2002-12-01 |
Family
ID=20418062
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15009000A IL150090A0 (en) | 1999-12-09 | 2000-12-04 | New (aminopropyl)methylphosphinic acids |
| IL150090A IL150090A (en) | 1999-12-09 | 2002-06-06 | Methylphosphinic (aminopropyl) acids |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL150090A IL150090A (en) | 1999-12-09 | 2002-06-06 | Methylphosphinic (aminopropyl) acids |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6596711B1 (OSRAM) |
| EP (1) | EP1239843A1 (OSRAM) |
| JP (1) | JP2003516346A (OSRAM) |
| KR (1) | KR100752010B1 (OSRAM) |
| CN (1) | CN1200713C (OSRAM) |
| AR (1) | AR033350A1 (OSRAM) |
| AU (1) | AU780259B2 (OSRAM) |
| BR (1) | BR0016291A (OSRAM) |
| CA (1) | CA2393510A1 (OSRAM) |
| CO (1) | CO5261538A1 (OSRAM) |
| CZ (1) | CZ20021984A3 (OSRAM) |
| EE (1) | EE200200287A (OSRAM) |
| HU (1) | HUP0300386A3 (OSRAM) |
| IL (2) | IL150090A0 (OSRAM) |
| IS (1) | IS6409A (OSRAM) |
| MX (1) | MXPA02005537A (OSRAM) |
| NO (1) | NO20022729L (OSRAM) |
| NZ (1) | NZ519377A (OSRAM) |
| PL (1) | PL357115A1 (OSRAM) |
| RU (1) | RU2267495C2 (OSRAM) |
| SE (1) | SE9904507D0 (OSRAM) |
| SK (1) | SK7632002A3 (OSRAM) |
| TW (1) | TWI225415B (OSRAM) |
| UA (1) | UA73149C2 (OSRAM) |
| WO (1) | WO2001041743A1 (OSRAM) |
| ZA (1) | ZA200204122B (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| US7319095B2 (en) * | 1999-12-09 | 2008-01-15 | Astrazeneca Ab | Use of GABAB receptor agonists |
| TW200407110A (en) | 2001-11-23 | 2004-05-16 | Astrazeneca Ab | New use for the treatment of gastroesophageal reflux disease |
| SE0201940D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination II |
| SE0201939D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination |
| DE10305463A1 (de) * | 2003-02-04 | 2004-08-12 | Schering Ag | Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel |
| SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
| EP1966154A4 (en) | 2005-12-23 | 2011-01-26 | Astrazeneca Ab | IMIDAZOLE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS |
| JP2009521430A (ja) | 2005-12-23 | 2009-06-04 | アストラゼネカ・アクチエボラーグ | Ｇａｂａ−ｂ受容体モジュレーター |
| ES2373255T3 (es) | 2007-05-04 | 2012-02-01 | Astrazeneca Ab | Proceso para s�?ntesis de �?cidos alquilfosf�?nicos mediante iniciación de una amina y un aminóxido. |
| JP2010534239A (ja) * | 2007-07-25 | 2010-11-04 | アストラゼネカ・アクチエボラーグ | Ｎｅｒｄの治療のための（３−アミノ−２−フルオロプロピル）ホスフィン酸の使用 |
| EP2235027A4 (en) * | 2007-12-21 | 2011-06-22 | Astrazeneca Ab | NEW CRYSTALLINE FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID |
| WO2009082344A1 (en) * | 2007-12-21 | 2009-07-02 | Astrazeneca Ab | Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a |
| JP2011026260A (ja) * | 2009-07-28 | 2011-02-10 | Central Glass Co Ltd | ３位に脱離基を有する２−フルオロプロピルアミン保護体または該アミンｎ−アルキル保護体 |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH449046A (de) | 1963-07-09 | 1967-12-31 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
| SU643510A1 (ru) * | 1975-04-11 | 1979-01-25 | Предприятие П/Я А-7815 | Способ получени о-аминофениларилфосфиновых кислот |
| SU589756A1 (ru) * | 1976-01-23 | 1982-10-07 | Институт Органической Химии Ан Усср | Способ получени солей перфторалкилфосфиновых кислот |
| GB8425872D0 (en) | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| WO1987004077A1 (en) | 1986-01-03 | 1987-07-16 | The University Of Melbourne | Gastro-oesophageal reflux composition |
| GB8820266D0 (en) | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| US5567840A (en) * | 1989-05-13 | 1996-10-22 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| US5281747A (en) * | 1989-05-13 | 1994-01-25 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| GB8911017D0 (en) | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| FR2663934B1 (fr) | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| FR2722192A1 (fr) | 1994-07-06 | 1996-01-12 | Adir | Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9420784D0 (en) | 1994-10-14 | 1994-11-30 | Glaxo Group Ltd | Medicaments |
| SE9603408D0 (sv) | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
-
1999
- 1999-12-09 SE SE9904507A patent/SE9904507D0/xx unknown
-
2000
- 2000-04-12 UA UA2002064506A patent/UA73149C2/uk unknown
- 2000-11-27 TW TW089125146A patent/TWI225415B/zh not_active IP Right Cessation
- 2000-12-04 JP JP2001543088A patent/JP2003516346A/ja active Pending
- 2000-12-04 PL PL00357115A patent/PL357115A1/xx not_active IP Right Cessation
- 2000-12-04 EP EP00986117A patent/EP1239843A1/en not_active Withdrawn
- 2000-12-04 SK SK763-2002A patent/SK7632002A3/sk not_active Application Discontinuation
- 2000-12-04 CN CNB008169063A patent/CN1200713C/zh not_active Expired - Fee Related
- 2000-12-04 NZ NZ519377A patent/NZ519377A/en unknown
- 2000-12-04 EE EEP200200287A patent/EE200200287A/xx unknown
- 2000-12-04 US US09/786,220 patent/US6596711B1/en not_active Expired - Fee Related
- 2000-12-04 CZ CZ20021984A patent/CZ20021984A3/cs unknown
- 2000-12-04 RU RU2002113916/04A patent/RU2267495C2/ru not_active Application Discontinuation
- 2000-12-04 MX MXPA02005537A patent/MXPA02005537A/es active IP Right Grant
- 2000-12-04 AU AU22412/01A patent/AU780259B2/en not_active Ceased
- 2000-12-04 CA CA002393510A patent/CA2393510A1/en not_active Abandoned
- 2000-12-04 BR BR0016291-4A patent/BR0016291A/pt not_active Application Discontinuation
- 2000-12-04 HU HU0300386A patent/HUP0300386A3/hu unknown
- 2000-12-04 KR KR1020027007356A patent/KR100752010B1/ko not_active Expired - Fee Related
- 2000-12-04 WO PCT/SE2000/002427 patent/WO2001041743A1/en not_active Ceased
- 2000-12-04 IL IL15009000A patent/IL150090A0/xx active IP Right Grant
- 2000-12-05 AR ARP000106429A patent/AR033350A1/es unknown
- 2000-12-06 CO CO00093168A patent/CO5261538A1/es not_active Application Discontinuation
-
2002
- 2002-05-23 ZA ZA200204122A patent/ZA200204122B/xx unknown
- 2002-06-06 IL IL150090A patent/IL150090A/en not_active IP Right Cessation
- 2002-06-06 IS IS6409A patent/IS6409A/is unknown
- 2002-06-07 NO NO20022729A patent/NO20022729L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200204122B (en) | 2003-10-29 |
| CA2393510A1 (en) | 2001-06-14 |
| SK7632002A3 (en) | 2003-03-04 |
| AU2241201A (en) | 2001-06-18 |
| CZ20021984A3 (cs) | 2002-11-13 |
| UA73149C2 (en) | 2005-06-15 |
| HUP0300386A2 (hu) | 2003-07-28 |
| PL357115A1 (en) | 2004-07-12 |
| AR033350A1 (es) | 2003-12-17 |
| RU2267495C2 (ru) | 2006-01-10 |
| EP1239843A1 (en) | 2002-09-18 |
| NO20022729L (no) | 2002-07-09 |
| CN1413104A (zh) | 2003-04-23 |
| MXPA02005537A (es) | 2004-09-10 |
| SE9904507D0 (sv) | 1999-12-09 |
| KR100752010B1 (ko) | 2007-08-28 |
| BR0016291A (pt) | 2002-08-13 |
| CN1200713C (zh) | 2005-05-11 |
| IS6409A (is) | 2002-06-06 |
| NO20022729D0 (no) | 2002-06-07 |
| TWI225415B (en) | 2004-12-21 |
| JP2003516346A (ja) | 2003-05-13 |
| NZ519377A (en) | 2003-11-28 |
| KR20020060993A (ko) | 2002-07-19 |
| RU2002113916A (ru) | 2004-01-10 |
| AU780259B2 (en) | 2005-03-10 |
| US6596711B1 (en) | 2003-07-22 |
| IL150090A (en) | 2006-08-01 |
| HK1053066A1 (en) | 2003-10-10 |
| EE200200287A (et) | 2003-08-15 |
| HUP0300386A3 (en) | 2005-08-29 |
| WO2001041743A1 (en) | 2001-06-14 |
| CO5261538A1 (es) | 2003-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0300301A3 (en) | New aminopropylphosphinic acids | |
| HUP0204092A3 (en) | Novel bisamidate phosphononate prodrugs | |
| IL150090A0 (en) | New (aminopropyl)methylphosphinic acids | |
| AU3022701A (en) | Dehydroamino acids | |
| GB0128994D0 (en) | Peptides | |
| HUP0202384A3 (en) | Substituted phenoxyacetic acids | |
| AU1497802A (en) | Ss-thio-amino acids | |
| EP1147130A4 (en) | ALPHA-conotoxin PEPTIDE | |
| GB9907285D0 (en) | Cycles | |
| GB9903408D0 (en) | Peptides | |
| HK1047711A (en) | New (aminopropyl)methylphosphinic acids | |
| TW414133U (en) | Magnetic socket | |
| GB2353949B (en) | Figurine | |
| SI1317426T1 (sl) | Beta-tio-aminokisline | |
| GB9904668D0 (en) | Glyphosate fprmulation | |
| GB9913845D0 (en) | The bouncy shoe | |
| GB9918593D0 (en) | Novel peptides | |
| GB9918595D0 (en) | Novel peptides | |
| GB9918601D0 (en) | Novel peptides | |
| GB9918596D0 (en) | Novel peptides | |
| GB9918598D0 (en) | Novel peptides | |
| GB9918606D0 (en) | Novel peptides | |
| GB9918594D0 (en) | Novel peptides | |
| GB9918603D0 (en) | Novel peptides | |
| GB9918599D0 (en) | Novel peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |